Evaluating differences in receipt of survivorship care plan among cancer survivors with and without disabilities.
Behavioral risk factor surveillance system
Cancer survivors
Disability
Survivorship care plan
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
05 Sep 2024
05 Sep 2024
Historique:
received:
12
03
2024
accepted:
08
08
2024
medline:
5
9
2024
pubmed:
5
9
2024
entrez:
5
9
2024
Statut:
epublish
Résumé
Despite the role of the Survivorship Care Plan (SCP) in facilitating treatment adherence, research on SCP receipt among cancer survivors with disabilities remains limited. Thus, our study investigated the association between SCP receipt and disability count among cancer survivors. We analyzed cross-sectional data from the 2021 Behavioral Risk Factor Surveillance System, Cancer Survivorship: Course of Treatment module. The final sample included 2271 respondents with self-reported cancer history. The outcome was self-reported SCP receipt (0 = did not receive SCP, 1 = received written summary or follow-up care instructions, and 2 = received SCP-both). Independent variable was disability counts, comprised of six types: hearing, vision, cognition, mobility, self-care, and independent living difficulties. Disability count was categorized into 0 = none, 1 one disability, 2 = two disabilities, and 3 = ≥ 3 disabilities. We conducted weighted descriptive statistics and multinomial multivariable logistic regression. The sample was mostly White (70.62%), female (59.42%), and aged ≥ 65 (54.88%). About 57% reported no disability, 20.89% reported 1-disability, 11.03% 2-disabilities, and 11.47% ≥ 3 disabilities. Mobility issues were the most common disability (26.86%), while self-care difficulties were the least common (6.40%). About 12.12% of cancer survivors did not receive SCP, 35.03% received either treatment summaries or follow-up care instructions, and 52.84% received SCP. Compared to those without disability, survivors with ≥ 3 disabilities had lower odds of receiving SCP (AOR 0.44, 95% CI 0.22-0.88, p = 0.022). This study suggests disparities in SCP receipt by disability count. Addressing such disparities can promote treatment adherence and reduction of missed follow-up.
Identifiants
pubmed: 39235704
doi: 10.1007/s00520-024-08796-6
pii: 10.1007/s00520-024-08796-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
637Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics. CA: A Cancer J Clin 74(1):12–49. https://doi.org/10.3322/caac.21820
Marzorati C, Riva S, Pravettoni G (2017) Who is a cancer survivor? A systematic review of published definitions. J Cancer Educ 32:228–237. https://doi.org/10.1007/s13187-016-0997-2
doi: 10.1007/s13187-016-0997-2
pubmed: 26854084
Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A et al (2022) Cancer treatment and survivorship statistics. CA Cancer J Clin 72(5):409–36. https://doi.org/10.3322/caac.21731
doi: 10.3322/caac.21731
pubmed: 35736631
National Cancer Institute. Statistics and Graphs. https://cancercontrol.cancer.gov/ocs/statistics . Accessed 16 Jul 2023
Stuver R, Faig J, Cadorette M, Decaneas W, Kaplan I, VanDeWege C et al (2020) Survivorship care plans: Reaching a benchmark and striving to achieve intent. JCO Oncol Pract 16(10):e1249–e1254. https://doi.org/10.1200/OP.20.00092
doi: 10.1200/OP.20.00092
pubmed: 32726174
American Cancer Society. ASCO cancer treatment and survivorship care plans. https://www.cancer.org/cancer/survivorship/long-term-health-concerns/survivorship-care-plans.html . Accessed 11 Feb 2024
McCabe MS, Bhatia S, Oeffinger KC, Reaman GH, Tyne C, Wollins DS et al (2013) American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol 31(5):631–640. https://doi.org/10.1200/jco.2012.46.6854
doi: 10.1200/jco.2012.46.6854
pubmed: 23295805
pmcid: 4878049
Centers for Disease Control and Prevention. Cancer survivorship care plans. https://www.cdc.gov/cancer-survivors/life-after-cancer/survivorship-care-plans.html . Accessed 17 Jul 2024
Lyson HC, Haggstrom D, Bentz M, Obeng-Gyasi S, Dixit N, Sarkar U (2021) Communicating Critical Information to Cancer Survivors: an Assessment of Survivorship Care Plans in Use in Diverse Healthcare Settings. J Cancer Educ 36(5):981–989. https://doi.org/10.1007/s13187-020-01725-1
doi: 10.1007/s13187-020-01725-1
pubmed: 32128714
pmcid: 7483188
Institute of Medicine and National Research Council (2006) From cancer patient to cancer survivor: lost in transition. The National Academies Press. Washington, DC. https://doi.org/10.17226/11468
Chahine S, Urquhart R (2019) A cross-sectional population-based survey looking at the impact of cancer survivorship care plans on meeting the needs of cancer survivors in the posttreatment stage. Support Care Cancer 27(10):3785–3792. https://doi.org/10.1007/s00520-019-04685-5
doi: 10.1007/s00520-019-04685-5
pubmed: 30721368
Linscott JA, Rutan MC, Han PKJ, Hansen MH, Hayn MH, Ryan ST et al (2020) Receipt of survivorship care plans and self-reported health status among patients with genitourinary malignancy. J Urol 204(3):564–569. https://doi.org/10.1097/ju.0000000000001032
doi: 10.1097/ju.0000000000001032
pubmed: 32267200
Shay LA, Schmidt S, Dioun SI, Grimes A, Embry L (2019) Receipt of a survivorship care plan and self-reported health behaviors among cancer survivors. J Cancer Surviv 13(2):180–186. https://doi.org/10.1007/s11764-019-00740-6
doi: 10.1007/s11764-019-00740-6
pubmed: 30767110
pmcid: 6483857
Benci JL, Vachani CC, Hampshire MK, Bach C, Arnold-Korzeniowski K, Metz JM et al (2020) Factors influencing delivery of cancer survivorship care plans: a national patterns of care study. Front Oncol 9:1577. https://doi.org/10.3389/fonc.2019.01577
doi: 10.3389/fonc.2019.01577
pubmed: 32083018
pmcid: 7005073
O’Regan P, Drummond E (2008) Cancer information needs of people with intellectual disability: A review of the literature. Eur J Oncol Nurs 12(2):142–147. https://doi.org/10.1016/j.ejon.2007.12.001
doi: 10.1016/j.ejon.2007.12.001
pubmed: 18321781
Berman BA, Jo AM, Cumberland WG, Booth H, Wolfson AA, Stern C et al (2017) D/deaf breast cancer survivors: their experiences and knowledge. J Health Care Poor Underserved 28(3):1165–1190. https://doi.org/10.1353/hpu.2017.0104
doi: 10.1353/hpu.2017.0104
pubmed: 28804085
Agaronnik ND, El-Jawahri A, Lindvall C, Iezzoni LI (2021) Exploring the Process of Cancer Care for Patients With Pre-Existing Mobility Disability. JCO Oncol Pract 17(1):e53–e61. https://doi.org/10.1200/op.20.00378
doi: 10.1200/op.20.00378
pubmed: 33351675
Agaronnik ND, El-Jawahri A, Iezzoni LI (2022) Implications of physical access barriers for breast cancer diagnosis and treatment in women with mobility disability. J Disabil Policy Stud 33(1):46–54. https://doi.org/10.1177/10442073211010124
doi: 10.1177/10442073211010124
pubmed: 35875606
Iezzoni LI (2022) Cancer detection, diagnosis, and treatment for adults with disabilities. Lancet Oncol 23(4):e164–e173. https://doi.org/10.1016/S1470-2045(22)00018-3
doi: 10.1016/S1470-2045(22)00018-3
pubmed: 35358465
Agaronnik N, Campbell EG, Ressalam J, Iezzoni LI (2019) Communicating with Patients with Disability: Perspectives of Practicing Physicians. J Gen Intern Med 34(7):1139–1145. https://doi.org/10.1007/s11606-019-04911-0
doi: 10.1007/s11606-019-04911-0
pubmed: 30887435
pmcid: 6614249
Tosetti I, Kuper H (2023) Do people with disabilities experience disparities in cancer care? A systematic review. PLoS ONE 18(12):e0285146. https://doi.org/10.1371/journal.pone.0285146
doi: 10.1371/journal.pone.0285146
pubmed: 38091337
pmcid: 10718463
Centers for Disease Control and Prevention. 2021 BRFSS survey data and documentation. https://www.cdc.gov/brfss/annual_data/annual_2021.html . Accessed 8 Jan 2023
Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System 2021 Summary Data Quality Report. 2022.
Department of Health and Human Services. Code of Federal Regulations. Title 45 Public Welfare. Part 46 Protection of Human Subjects. https://www.hhs.gov/ohrp/sites/default/files/ohrp/policy/ohrpregulations.pdf . Accessed 16 Jul 2023
Centers for Disease Control and Prevention. 2021 BRFSS Questionnaire. https://www.cdc.gov/brfss/questionnaires/index.htm . Accessed 16 Jul 2023
Rapoport E, Bjurlin MA, Furberg H, Donahue TF, Taneja SS, Bochner BH et al (2023) Smoking cessation pharmacotherapy use during index hospital admission following cystectomy for bladder cancer: a retrospective cohort study. Urologic Oncol Semin Orig Invest 41(6):295.e1-e8. https://doi.org/10.1016/j.urolonc.2022.11.013
doi: 10.1016/j.urolonc.2022.11.013
Timsina LR, Zarzaur B, Haggstrom DA, Jenkins PC, Lustberg M, Obeng-Gyasi S (2021) Dissemination of cancer survivorship care plans: who is being left out? Support Care Cancer 29:4295–4302. https://doi.org/10.1007/s00520-020-05915-x
doi: 10.1007/s00520-020-05915-x
pubmed: 33415363
Jin M, Jones MR, Connor AE (2024) Racial disparities in receipt of survivorship care plans among female cancer survivors in Maryland. Front Cancer Control Soc 1:1330410. https://doi.org/10.3389/fcacs.2023.1330410
doi: 10.3389/fcacs.2023.1330410
Tarver WL, Justice Z, Jonnalagadda P, Rahurkar S, Obeng-Gyasi S, Krok-Schoen JL et al (2024) A scoping review of the evidence on survivorship care plans among minority, rural, and low-income populations. J Cancer Surviv. https://doi.org/10.1007/s11764-024-01609-z
Kelleher SA, Dorfman CS, Winger JG, Winett RA, Graves KD (2021) Survivorship care plans: initial evidence of impact on distress and self-efficacy among high-risk cancer survivors. J Oncol Navigation Surviv 12(1)
Iezzoni LI, Rao SR, Ressalam J, Bolcic-Jankovic D, Agaronnik ND, Donelan K et al (2021) Physicians’ perceptions of people with disability and their health care: study reports the results of a survey of physicians’ perceptions of people with disability. Health Aff 40(2):297–306. https://doi.org/10.1377/hlthaff.2020.01452
doi: 10.1377/hlthaff.2020.01452
Gallicchio L, Tonorezos E, de Moor JS, Elena J, Farrell M, Green P et al (2021) Evidence gaps in cancer survivorship care: a report from the 2019 national cancer institute cancer survivorship workshop. J Natl Cancer Inst 113(9):1136–1142. https://doi.org/10.1093/jnci/djab049
doi: 10.1093/jnci/djab049
pubmed: 33755126
pmcid: 8418428
Chu AK, Mutsaers B, Lebel S (2022) The association between survivorship care plans and patient-reported satisfaction and confidence with follow-up cancer care provided by primary care providers. Curr Oncol 29(10):7343–7354. https://doi.org/10.3390/curroncol29100577
doi: 10.3390/curroncol29100577
pubmed: 36290854
pmcid: 9600139
Blanch-Hartigan D, Forsythe LP, Alfano CM, Smith T, Nekhlyudov L, Ganz PA et al (2014) Provision and discussion of survivorship care plans among cancer survivors: results of a nationally representative survey of oncologists and primary care physicians. J Clin Oncol 32(15):1578–1585. https://doi.org/10.1200/jco.2013.51.7540
doi: 10.1200/jco.2013.51.7540
pubmed: 24752057
pmcid: 4026581
Mayer DK, Nekhlyudov L, Snyder CF, Merrill JK, Wollins DS, Shulman LN (2014) American society of clinical oncology clinical expert statement on cancer survivorship care planning. J Oncol Pract 10(6):345–351. https://doi.org/10.1200/JOP.2014.001321
doi: 10.1200/JOP.2014.001321
pubmed: 25316025
Haggstrom DA, Kahn KL, Klabunde CN, Gray SW, Keating NL (2021) Oncologists’ perceptions of the usefulness of cancer survivorship care plan components. Support Care Cancer 29(2):945–954. https://doi.org/10.1007/s00520-020-05531-9
doi: 10.1007/s00520-020-05531-9
pubmed: 32537684
de Rooij BH, Ezendam NPM, Vos MC, Pijnenborg JMA, Boll D, Kruitwagen R et al (2019) Patients’ information coping styles influence the benefit of a survivorship care plan in the ROGY care trial: new insights for tailored delivery. Cancer 125(5):788–797. https://doi.org/10.1002/cncr.31844
doi: 10.1002/cncr.31844
pubmed: 30500067